Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

Pfizer Inc. today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor TUKYSA® (tucatinib) as part of an investigational first-line maintenance treatment ...

International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...

Zentalis has taken a beating in 2025 to date, as the market continues to value their pipeline as a liability rather than an ...

The fabrication of two-dimensional covalent organic framework films with uniform thickness, ordered structure and excellent semiconducting performance directly on substrates for applications in ...

BackBiome honey-based probiotic formula combines seven researched bacterial strains including Bacillus subtilis to support ...

Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared first-in-human data from the ongoing inMMyCARTM study, a Phase 1 clinical trial ...

Materials informatics combines data analytics and engineering design, streamlining material development and enhancing performance through AI integration.

Sweat is turning into one of medicine’s most revealing data streams, and artificial intelligence is learning how to read it.

Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.